APOE, a significant risk gene for AD, has been found by Van et al. to potentially prevent chemotherapy-related cognitive decline in elderly breast cancer survivors with the APOE ε2 polymorphism (Van Dyk et al., 2021). The gene discussed is APOE; the disease is Alzheimer disease.